The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Reprogramming the Chromatin Landscape: Interplay of the Estrogen and Glucocorticoid Receptors at the Genomic Level
Open accessPublished version of a preprint
Abstract
Cross-talk between estrogen receptors (ER) and glucocorticoid receptors (GR) has been shown to contribute to the development and progression of breast cancer. Importantly, the ER and GR status in breast cancer cells is a significant factor in determining the outcome of the disease. However, mechanistic details defining the cellular interactions between ER and GR are poorly understood. We investigated genome-wide binding profiles for ER and GR upon coactivation and characterized the status of the chromatin landscape. We describe a novel mechanism dictating the molecular interplay between ER and GR. Upon induction, GR modulates access of ER to specific sites in the genome by reorganization of the chromatin configuration for these elements. Binding to these newly accessible sites occurs either by direct recognition of ER response elements or indirectly through interactions with other factors. The unveiling of this mechanism is important for understanding cellular interactions between ER and GR and may represent a general mechanism for cross-talk between nuclear receptors in human disease. Cancer Res; 73(16); 5130–9. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Assisted loading has been described in various systems30–37.”
From Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading (2017) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Chromatin accessibility pre-determines glucocorticoid receptor binding patterns
John, S., Sabo, P. J., Thurman, R. E., Sung, M.-H., Biddie, S. C., Johnson, T. A., Hager, G. L., & Stamatoyannopoulos, J. A. (2011) · Nature Genetics · doi:10.1038/ng.759 · Cited by 954
Self-citationFOXA1 is a key determinant of estrogen receptor function and endocrine response
Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D., & Carroll, J. S. (2010) · Nature Genetics · doi:10.1038/ng.730 · Cited by 864
Webb, P., Lopez, G. N., Uht, R. M., & Kushner, P. J. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.4.7659088 · Cited by 694
The Fos family of transcription factors and their role in tumourigenesis
Milde-Langosch, K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.008 · Cited by 583
Global mapping of protein-DNA interactions in vivo by digital genomic footprinting
Hesselberth, J. R., Chen, X., Zhang, Z., Sabo, P. J., Sandstrom, R., Reynolds, A. P., Thurman, R. E., Neph, S., Kuehn, M. S., Noble, W. S., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1313 · Cited by 559
Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding
Biddie, S. C., John, S., Sabo, P. J., Thurman, R. E., Johnson, T. A., Schiltz, R. L., Miranda, T. B., Sung, M.-H., Trump, S., Lightman, S. L., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.016 · Cited by 503
Self-citationActivation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
Gaub, M., Gross-Bellard, M., Scheuer, I., Chambon, P., & Sassone‐Corsi, P. (1990) · Cell · doi:10.1016/0092-8674(90)90422-b · Cited by 467
Ham, J., Thomson, A. A., Needham, M., Webb, P., & Parker, M. G. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.12.5263 · Cited by 339
Herrera, R. E., Shaw, P. E., & Nordheim, A. (1989) · Nature · doi:10.1038/340068a0 · Cited by 322
Cited by
Sorted by citations
Mechanisms of enhancer action: the known and the unknown
Panigrahi, A., & O’Malley, B. W. (2021) · Genome biology · doi:10.1186/s13059-021-02322-1 · Cited by 378
Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions
Swinstead, E. E., Miranda, T. B., Paakinaho, V., Baek, S., Goldstein, I., Hawkins, M., Karpova, T. S., Ball, D., Mazza, D., Lavis, L. D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.067 · Cited by 312
Self-citationEstrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
Rodriguez, A. C., Blanchard, Z., Maurer, K. A., & Gertz, J. (2019) · Hormones and Cancer · doi:10.1007/s12672-019-0358-9 · Cited by 303
Nuclear receptor crosstalk — defining the mechanisms for therapeutic innovation
Bosscher, K. D., Desmet, S. J., Clarisse, D., Estébanez‐Perpiñá, E., & Brunsveld, L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0349-5 · Cited by 206
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancerPreprint
Siersbæk, R., Kumar, S. S., & Carroll, J. S. (2018) · Genes & Development · doi:10.1101/gad.316646.118 · Cited by 148
Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action
Oh, K., Patel, H., Gottschalk, R. A., Lee, W. S., Baek, S., Fraser, I. D. C., Hager, G. L., & Sung, M. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.012 · Cited by 148
Self-citationDeterminants of Receptor- and Tissue-Specific Actions in Androgen Signaling
Pihlajamaa, P., Sahu, B., & Jänne, O. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1034 · Cited by 143
Grøntved, L., Waterfall, J. J., Kim, D. W., Baek, S., Sung, M., Zhao, L., Park, J. W., Nielsen, R., Walker, R. L., Zhu, Y. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8048 · Cited by 142
Self-citationThe new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer
Jordan, V. C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0448 · Cited by 135
Deciphering the divergent roles of progestogens in breast cancer
Carroll, J. S., Hickey, T. E., Tarulli, G. A., Williams, M. R., & Tilley, W. D. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.116 · Cited by 126
West-Szymanski, D. C., Pan, D., Tonsing-Carter, E. Y., Hernandez, K. M., Pierce, C. F., Styke, S. C., Bowie, K. R., Garcia, T. I., Kocherginsky, M., & Conzen, S. D. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0433 · Cited by 123
Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response
Goldstein, I., Baek, S., Presman, D. M., Paakinaho, V., Swinstead, E. E., & Hager, G. L. (2017) · Genome Research · doi:10.1101/gr.212175.116 · Cited by 121
Self-citationNuclear receptors in cancer — uncovering new and evolving roles through genomic analysis
Dhiman, V. K., Bolt, M. J., & White, K. P. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.102 · Cited by 117
Oxytocin receptor DNA methylation in postpartum depression
Kimmel, M., Clive, M. L., Gispen, F. E., Guintivano, J., Brown, T., Cox, O., Beckmann, M. W., Kornhuber, J., Fasching, P. A., Osborne, L. M., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.008 · Cited by 118
Goldstein, I., Paakinaho, V., Baek, S., Sung, M.-H., & Hager, G. L. (2017) · Nature Communications · doi:10.1038/s41467-017-02055-5 · Cited by 97
Self-citationVoutsadakis, I. A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010011 · Cited by 94
EJE PRIZE 2016: Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer
Carroll, J. S. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0124 · Cited by 96
Stavreva, D. A., Coulon, A., Baek, S., Sung, M., John, S., Stixová, L., Tesikova, M., Hakim, O., Miranda, T. B., Hawkins, M. E., et al. (2015) · Genome Research · doi:10.1101/gr.184168.114 · Cited by 97
Self-citationTonsing-Carter, E. Y., Hernandez, K. M., Kim, C. R., Harkless, R. V., Oh, A., Bowie, K. R., West-Szymanski, D. C., Betancourt-Ponce, M. A., Green, B., Lastra, R. R., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1164-6 · Cited by 79
Targeting the glucocorticoid receptor in breast and prostate cancers
Kach, J., Conzen, S. D., & Szmulewitz, R. Z. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7531 · Cited by 74
Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers
Truong, T. H., & Lange, C. A. (2018) · Endocrinology · doi:10.1210/en.2018-00831 · Cited by 73
Endocrine disruptors of sex hormone activities
Varticovski, L., Stavreva, D. A., McGowan, A., Raziuddin, R., & Hager, G. L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111415 · Cited by 75
Self-citationGlucocorticoid regulation of cancer development and progression
Khadka, S., Druffner, S. R., Duncan, B. C., & Busada, J. T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1161768 · Cited by 75
Vahrenkamp, J. M., Yang, C.-H., Rodriguez, A. C., Almomen, A. A., Berrett, K. C., Trujillo, A., Guillen, K. P., Welm, B. E., Jarboe, E. A., Janat-Amsbury, M. M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.076 · Cited by 72
Yang, F., Ma, Q., Liu, Z., Li, W., Tan, Y., Jin, C., Ma, W., Hu, Y., Shen, J., Ohgi, K. A., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.019 · Cited by 73
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
Seachrist, D. D., Anstine, L. J., & Keri, R. (2021) · Cancers · doi:10.3390/cancers13205205 · Cited by 68
Wiley, J. W., Higgins, G. A., & Athey, B. D. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12706 · Cited by 66
Transcription Factor Dynamics: One Molecule at a Time
Wagh, K., Stavreva, D. A., Upadhyaya, A., & Hager, G. L. (2023) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-022823-013847 · Cited by 68
Self-citationGender Bias in Human Systemic Lupus Erythematosus: A Problem of Steroid Receptor Action?
Rider, V., Abdou, N. I., Kimler, B. F., Lu, N., Brown, S. J., & Fridley, B. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00611 · Cited by 62
Genome-Wide Estrogen Receptor Activity in Breast Cancer
Farcas, A. M., Nagarajan, S., Cosulich, S. C., & Carroll, J. S. (2020) · Endocrinology · doi:10.1210/endocr/bqaa224 · Cited by 60
Genome-wide crosstalk between steroid receptors in breast and prostate cancers
Paakinaho, V., & Palvimo, J. (2021) · Endocrine-Related Cancer · doi:10.1530/erc-21-0038 · Cited by 35
Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer
Noureddine, L. M., Trédan, O., Hussein, N., Badran, B. M., Romancer, M. L., & Poulard, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094446 · Cited by 58
Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease
Manoli, D. S., & Tollkühn, J. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13564 · Cited by 58
Epigenomic PU.1-VDR crosstalk modulates vitamin D signaling
Seuter, S., Neme, A., & Carlberg, C. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.02.005 · Cited by 51
Burris, T. P., de Vera, I. M. S., Côté, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., Walker, J. K., Steinauer, N., Zhang, J., Coons, L. A., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000436 · Cited by 54
Novel DNA Motif Binding Activity Observed In Vivo With an Estrogen Receptor α Mutant Mouse
Hewitt, S. C., Li, L., Grimm, S. A., Winuthayanon, W., Hamilton, K. J., Pockette, B., Rubel, C. A., Pedersen, L. C., Fargo, D. C., Lanz, R. B., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1051 · Cited by 50
Bacon, E. R., & Brinton, R. D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.040 · Cited by 52
HNF4A modulates glucocorticoid action in the liver
Hunter, A. L., Poolman, T. M., Kim, D., Gonzalez, F. J., Bechtold, D. A., Loudon, A. S. I., Iqbal, M., & Ray, D. W. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110697 · Cited by 49
Glucocorticoid receptor positively regulates transcription of FNDC5 in the liver
Kim, H. K., Jeong, Y. J., Song, I.-S., Noh, Y. H., Seo, K. W., Kim, M., & Han, J. (2017) · Scientific Reports · doi:10.1038/srep43296 · Cited by 50
Baken, K. A., Lambrechts, N., Rémy, S., Mustieles, V., Rodríguez‐Carrillo, A., Neophytou, C. M., Olea, N., & Schoeters, G. E. R. (2019) · Environmental Research · doi:10.1016/j.envres.2019.05.013 · Cited by 48
Nuclear receptors and chromatin: an inducible couple
Gadaleta, R. M., & Magnani, L. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0170 · Cited by 52
Cell type specificity of glucocorticoid signaling in the adult mouse hippocampus
Viho, E. M. G., Buurstede, J. C., Berkhout, J. B., Mahfouz, A. E., & Meijer, O. C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13072 · Cited by 47
Sweeney, E. E., Fan, P., & Jordan, V. C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1784 · Cited by 45
Ogara, M. F., Rodríguez‐Seguí, S. A., Marini, M., Nacht, A. S., Stortz, M., Levi, V., Presman, D. M., Vicent, G. P., & Pecci, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz857 · Cited by 45
Structures and consequences of pioneer factor binding to nucleosomes
Luzete-Monteiro, E., & Zaret, K. S. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102425 · Cited by 43
Ruíz, D., Padmanabhan, V., & Sargis, R. M. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa087 · Cited by 46
Chromatin Remodeler Mutations in Human Cancers: Epigenetic Implications
Giles, K. A., Phan, L., Clark, S. J., & Taberlay, P. C. (2014) · Epigenomics · doi:10.2217/epi.14.37 · Cited by 40
Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function
Jiang, G., Wang, X., Sheng, D., Zhou, L., Liu, Y., Xu, C., Liu, S., & Zhang, J. (2019) · Theranostics · doi:10.7150/thno.34874 · Cited by 41
Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression
Oh, K., Gottschalk, R. A., Lounsbury, N., Sun, J., Dorrington, M. G., Baek, S., Sun, G., Wang, Z., Krauss, K. S., Milner, J. D., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800158 · Cited by 39
Self-citationSteroid metabolism in breast cancer: Where are we and what are we missing?
Africander, D., & Storbeck, K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.016 · Cited by 40
Possible roles for glucocorticoid signalling in breast cancer
McNamara, K. M., Kanai, A., & Sasano, H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.004 · Cited by 36
The Three Ds of Transcription Activation by Glucagon: Direct, Delayed, and Dynamic
Goldstein, I., & Hager, G. L. (2017) · Endocrinology · doi:10.1210/en.2017-00521 · Cited by 36
Self-citationMeta-analysis of Chromatin Programming by Steroid Receptors
Paakinaho, V., Swinstead, E. E., Presman, D. M., Grøntved, L., & Hager, G. L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.039 · Cited by 34
Self-citationWen, X., Xiao, Y., Xiao, H., Tan, X., Wu, B., Li, Z., Wang, R., Xu, X., & Li, T. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113504 · Cited by 29
Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives
Faldoni, F. L. C., Rainho, C. A., & Rogatto, S. R. (2020) · Cells · doi:10.3390/cells9051164 · Cited by 29
Chen, Y., Xu, D., Xia, X., Chen, G., Xiao, H., Chen, L., & Wang, H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105942 · Cited by 29
Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies
Hancock, G. R., Gertz, J., Jeselsohn, R. M., & Fanning, S. W. (2024) · Endocrinology · doi:10.1210/endocr/bqae051 · Cited by 28
Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression
Butz, H., & Patócs, A. (2022) · Cancer metastasis reviews · doi:10.1007/s10555-022-10047-1 · Cited by 27
Pooley, J. R., Flynn, B. P., Grøntved, L., Baek, S., Guertin, M. J., Kershaw, Y. M., Birnie, M. T., Pellatt, A., Rivers, C. A., Schiltz, R. L., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1929 · Cited by 27
Self-citationFelsenfeld, G. (2014) · Perspectives in biology and medicine · doi:10.1353/pbm.2014.0004 · Cited by 26
Dynamic enhancer function in the chromatin context
Goldstein, I., & Hager, G. L. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1390 · Cited by 25
Self-citationHormone therapy and breast cancer: emerging steroid receptor mechanisms
Perkins, M., Toit, R. L.-D., & Africander, D. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0094 · Cited by 25
Macrophagic AMPKα1 orchestrates regenerative inflammation induced by glucocorticoids
Caratti, G., Desgeorges, T., Juban, G., Stifel, U., Fessard, A., Koenen, M., Caratti, B., Théret, M., Skurk, C., Chazaud, B., et al. (2022) · EMBO Reports · doi:10.15252/embr.202255363 · Cited by 23
Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density
Grahnemo, L., Jochéms, C., Andersson, A., Engdahl, C., Ohlsson, C., Islander, U., & Carlsten, H. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0508 · Cited by 24
Tangen, I. L., Veneris, J. T., Halle, M. K., Werner, H. M. J., Trovik, J., Akslen, L. A., Salvesen, H. B., Conzen, S. D., Fleming, G. F., & Krakstad, C. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.09.013 · Cited by 24
Fan, P., Siwak, D. R., Abderrahman, B., Agboke, F. A., Yerrum, S., & Jordan, V. C. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1363 · Cited by 24
Chromatin structure and gene regulation: a dynamic view of enhancer function
Stavreva, D. A., & Hager, G. L. (2015) · Nucleus · doi:10.1080/19491034.2015.1107689 · Cited by 24
Self-citationChromatin reprogramming in breast cancer
Swinstead, E. E., Paakinaho, V., & Hager, G. L. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0033 · Cited by 24
Self-citationVijeyakumaran, M., Jawhri, M. A., Fortunato, J., Solomon, L. A., Palikhe, N. S., Vliagoftis, H., & Cameron, L. (2022) · Allergy · doi:10.1111/all.15543 · Cited by 22
Minireview: Conversing With Chromatin: The Language of Nuclear Receptors
Biddie, S. C., & John, S. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1247 · Cited by 22
Self-citationEstrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer.
Mayayo-Peralta, I., Preković, S., & Zwart, W. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100939 · Cited by 16
Sikora, M. J. (2016) · Endocrinology · doi:10.1210/en.2016-1778 · Cited by 21
Coons, L. A., Hewitt, S. C., Burkholder, A., McDonnell, D. P., & Korach, K. S. (2017) · Endocrinology · doi:10.1210/en.2017-00468 · Cited by 20
Genistein Disrupts Glucocorticoid Receptor Signaling in Human Uterine Endometrial Ishikawa Cells
Whirledge, S., Senbanjo, L. T., & Cidlowski, J. A. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1408437 · Cited by 20
Glucocorticoid receptor action in prostate cancer: the role of transcription factor crosstalk
Hiltunen, J., Helminen, L., & Paakinaho, V. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1437179 · Cited by 18
Bagamasbad, P., Espina, J. E. C., Knoedler, J. R., Subramani, A., Harden, A. J., & Denver, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220378 · Cited by 17
Snider, H., Villavarajan, B., Peng, Y.-W. P., Shepherd, L., Robinson, A. C., & Mueller, C. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0750-x · Cited by 15
Whirledge, S., Kisanga, E. P., Taylor, R. N., & Cidlowski, J. A. (2017) · Endocrinology · doi:10.1210/en.2017-00361 · Cited by 17
Moore, N. L. T., Hanson, A. R., Ebrahimie, E., Hickey, T. E., & Tilley, W. D. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105548 · Cited by 17
Intabli, H., Gee, J. M. W., Oesterreich, S., Yeoman, M. S., Allen, M. C., Qattan, A. T., & Flint, M. S. (2022) · Gene · doi:10.1016/j.gene.2022.147022 · Cited by 15
Susa, T., Ikaga, R., Kajitani, T., Iizuka, M., Okinaga, H., Tamamori‐Adachi, M., & Okazaki, T. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24906 · Cited by 14
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic
Kumar, S. S., Freelander, A., & Lim, E. (2021) · Cancers · doi:10.3390/cancers13194972 · Cited by 15
Laryea, G. N., Arnett, M. G., & Muglia, L. J. (2015) · Stress · doi:10.3109/10253890.2015.1046832 · Cited by 13
Jallow, F., Brockman, J. L., Helzer, K. T., Rugowski, D. E., Goffin, V., Alarid, E. T., & Schuler, L. A. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00399 · Cited by 12
Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtype.
Abigail, B., & Suzanne, D. (2024) · Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106518 · Cited by 8
Posani, S. H., Gillis, N. E., & Lange, C. A. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106575 · Cited by 12
How far have we come in terms of estrogens in breast cancer? [Review]
McNamara, K. M., Guestini, F., Sakurai, M., Kikuchi, K., & Sasano, H. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0022 · Cited by 11
Porter, B. A., Frerich, C., Lainé, M., Clark, A. B., Durdana, I., Lee, J., Taya, M., Sahoo, S., Greene, G. L., Bennett, L. B., et al. (2023) · Cancers · doi:10.3390/cancers15194679 · Cited by 10
Mianesaz, H., Göczi, L., Nagy, G., Póliska, S., Fadel, L., Bojcsuk, D., Penyige, A., Szirák, K., AlHaman, F., Nagy, L., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf230 · Cited by 10
Hiltunen, J., Helminen, L., Aaltonen, N., Launonen, K., Laakso, H., Malinen, M., Niskanen, E. A., Palvimo, J. J., & Paakinaho, V. (2025) · Genome Research · doi:10.1101/gr.280224.124 · Cited by 10
Oakley, R. H., Riddick, N. V., Moy, S. S., & Cidlowski, J. A. (2023) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100589 · Cited by 9
Glucocorticoids—timing, binding and environment
Lightman, S. L., & George, C. L. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.257 · Cited by 9
Dhaibar, H. A., & Cruz‐Topete, D. (2021) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2021.606833 · Cited by 8
Context-Dependent Role of Glucocorticoid Receptor Alpha and Beta in Breast Cancer Cell Behaviour
Butz, H., Saskői, É., Krokker, L., Vereczki, V., Alpár, A., Likó, I., Tóth, E., Szőcs, E., Cserepes, M., Nagy, K., et al. (2023) · Cells · doi:10.3390/cells12050784 · Cited by 6
Liu, Y., & Jeong, K. W. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0343 · Cited by 7
Estrogen-regulated miRs in bone enhance osteoblast differentiation and matrix mineralization
Emch, M. J., Wicik, Z., Aspros, K. G. M., Vukajlovic, T., Pitel, K. S., Narum, A. K., Weivoda, M. M., Tang, X., Kalari, K. R., Turner, R. T., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.026 · Cited by 7
Xie, L., Jiao, Z., Zhang, H., Wang, T., Qin, J., Zhang, S., Luo, M., Lu, M., Yao, B., Wang, H., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2022.05.004 · Cited by 6
BAF Complexes and the Glucocorticoid Receptor in Breast Cancers
Dietrich, N., Hoffman, J. A., & Archer, T. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.07.001 · Cited by 7
Sarusi-Portuguez, A., Grbeša, I., Tal, M., Deitch, R., Raz, D., Weismann, R., Schwartz, M., Loza, O., Sung, M., Kaplan, T., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/764480 · Cited by 6
Self-citationSun, G., Zhao, C., Han, J., Wu, S., Chen, Y., Yao, J., & Li, L. (2024) · Cellular Oncology · doi:10.1007/s13402-024-01011-y · Cited by 5
Metadata
- Authors
- Miranda, T. B., Voss, T. C., Sung, M.-H., Baek, S., John, S., Hawkins, M., Grøntved, L., Schiltz, R. L., & Hager, G. L.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Hager, Gordon L.
- Venue
- Cancer Research
- Published
- 2013-08-13
- Volume
- 73
- Issue
- 16
- Pages
- 5130-5139
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC3799864
- OpenAlex
- W2109796629
- Cited by
- 130
- References
- 41
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 15 · 2020: 6 · 2019: 14 · 2018: 13 · 2017: 14 · 2016: 10 · 2015: 7 · 2014: 9 · 2013: 4
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Lundbeckfonden
- National Institutes of Health
- National Cancer Institute (Z01BC005450)
- National Institute of General Medical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- estrogen receptor, glucocorticoid receptor, chromatin accessibility, chromatin reorganization, breast cancer, transcriptional regulation
- MeSH terms
- Animals, Binding Sites, Cell Line, Chromatin, DNA, Protein Binding, Receptors, Estrogen, Receptors, Glucocorticoid, Genome, Response Elements, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review